U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 110

1.
Selective activation of PFKL suppresses the phagocytic oxidative burst
Neri Amara, Madison P. Cooper, Maria A. Voronkova, Bradley A. Webb, Eric M. Lynch, Justin M. Kollman, Taylur Ma, Kebing Yu, Zijuan Lai, Dewakar Sangaraju, Nobuhiko Kayagaki, Kim Newton, Matthew Bogyo, Steven T. Staben, Vishva M. Dixit
Cell. Author manuscript; available in PMC 2022 Jan 31.
Published in final edited form as: Cell. 2021 Aug 19; 184(17): 4480–4494.e15. Published online 2021 Jul 27. doi: 10.1016/j.cell.2021.07.004
PMCID:
PMC8802628
AbstractArticlePDF–2.0M
2.
A DNA polymorphism with KpnI of the human liver-type phosphofructokinase (PFKL) gene.
A C Warren, Y Groner, S E Antonarakis
Nucleic Acids Res. 1988 Sep 26; 16(18): 9060. doi: 10.1093/nar/16.18.9060
PMCID:
PMC338670
SummaryPage BrowsePDF–74K
3.
Dinucleotide repeat polymorphism at the human liver-type 6-phosphofructokinase (PFKL) gene
Mihael H. Polymeropoulos, Denise S. Rath, Hong Xiao, Carl R. Merril
Nucleic Acids Res. 1991 May 11; 19(9): 2517. doi: 10.1093/nar/19.9.2517
PMCID:
PMC329487
SummaryPage BrowsePDF–153K
4.
Assignment of the human gene for liver-type 6-phosphofructokinase isozyme (PFKL) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L antibody.
S Vora, U Francke
Proc Natl Acad Sci U S A. 1981 Jun; 78(6): 3738–3742. doi: 10.1073/pnas.78.6.3738
PMCID:
PMC319647
SummaryPage BrowsePDF–1.0M
5.
A contiguous Not I restriction map of band q22.3 of human chromosome 21.
D Wang, H Fang, C R Cantor, C L Smith
Proc Natl Acad Sci U S A. 1992 Apr 15; 89(8): 3222–3226. doi: 10.1073/pnas.89.8.3222
PMCID:
PMC48838
SummaryPage BrowsePDF–1.1M
6.
Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma
Xingming Zhang, Lou Geng, Yi Tang, Yingying Wang, Youping Zhang, Chujiao Zhu, Hu Lei, Hanzhang Xu, Qi Zhu, Yingli Wu, Wenli Gu
J Transl Med. 2024; 22: 193. Published online 2024 Feb 22. doi: 10.1186/s12967-024-04943-z
PMCID:
PMC10885370
AbstractArticlePDF–11M
7.
EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL
Mingang Pan, Muyu Luo, Lele Liu, Yunmeng Chen, Ziyi Cheng, Kai Wang, Luyi Huang, Ni Tang, Jianguo Qiu, Ailong Huang, Jie Xia
J Exp Clin Cancer Res. 2024; 43: 35. Published online 2024 Jan 29. doi: 10.1186/s13046-024-02957-5
PMCID:
PMC10823730
AbstractArticlePDF–4.8M
8.
The glycolytic enzyme phosphofructokinase-1 assembles into filaments
Bradley A. Webb, Anne M. Dosey, Torsten Wittmann, Justin M. Kollman, Diane L. Barber
J Cell Biol. 2017 Aug 7; 216(8): 2305–2313. doi: 10.1083/jcb.201701084
PMCID:
PMC5551713
AbstractArticlePDF–2.0M
9.
Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.
S Vora, M Davidson, C Seaman, A F Miranda, N A Noble, K R Tanaka, E P Frenkel, S Dimauro
J Clin Invest. 1983 Dec; 72(6): 1995–2006. doi: 10.1172/JCI111164
PMCID:
PMC437040
SummaryPage BrowsePDF–2.0M
10.
DNAAF5 promotes hepatocellular carcinoma malignant progression by recruiting USP39 to improve PFKL protein stability
Yaping Liu, Qiong Wu, Tiantian Sun, Junxing Huang, Gaohua Han, Hexu Han
Front Oncol. 2022; 12: 1032579. Published online 2022 Oct 6. doi: 10.3389/fonc.2022.1032579
PMCID:
PMC9582515
AbstractArticlePDF–5.4M
11.
Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches
Peter M. Fernandes, James Kinkead, Iain McNae, Paul A.M. Michels, Malcolm D. Walkinshaw
Biochem J. 2020 Nov 27; 477(22): 4425–4441. Prepublished online 2020 Nov 3. Published online 2020 Nov 27. doi: 10.1042/BCJ20200656
PMCID:
PMC7702303
AbstractArticlePDF–3.2M
12.
TAp73-induced phosphofructokinase-1 transcription promotes the Warburg effect and enhances cell proliferation
Le Li, Lijia Li, Wei Li, Taiqi Chen, Bin Zou, Lina Zhao, Huili Wang, Xueying Wang, Lina Xu, Xiaohui Liu, Dong Wang, Bo Li, Tak W. Mak, Wenjing Du, Xiaolu Yang, Peng Jiang
Nat Commun. 2018; 9: 4683. Published online 2018 Nov 8. doi: 10.1038/s41467-018-07127-8
PMCID:
PMC6224601
AbstractArticlePDF–1.8M
13.
PFK1 Glycosylation Is a Key Regulator of Cancer Cell Growth and Central Metabolic Pathways
Wen Yi, Peter M. Clark, Daniel E. Mason, Marie C. Keenan, Collin Hill, William A. Goddard, III, Eric C. Peters, Edward M. Driggers, Linda C. Hsieh-Wilson
Science. Author manuscript; available in PMC 2013 Jan 3.
Published in final edited form as: Science. 2012 Aug 24; 337(6097): 975–980. doi: 10.1126/science.1222278
PMCID:
PMC3534962
AbstractArticlePDF–1.4M
14.
Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat
Richard L Seip, Jeff S Volek, Andreas Windemuth, Mohan Kocherla, Maria Luz Fernandez, William J Kraemer, Gualberto Ruaño
Nutr Metab (Lond) 2008; 5: 4. Published online 2008 Feb 6. doi: 10.1186/1743-7075-5-4
PMCID:
PMC2270845
AbstractArticlePDF–397K
15.
A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma
Yilu Feng, Ye Zhang, Yi Cai, Ruijie Liu, Miaolong Lu, Tangzhiming Li, Ying Fu, Ming Guo, Huichao Huang, Yifu Ou, Yongheng Chen
Cell Death Dis. 2020 Feb; 11(2): 89. Published online 2020 Feb 3. doi: 10.1038/s41419-020-2278-6
PMCID:
PMC6997366
AbstractArticlePDF–3.3M
16.
Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.
N Raben, R Exelbert, R Spiegel, J B Sherman, H Nakajima, P Plotz, J Heinisch
Am J Hum Genet. 1995 Jan; 56(1): 131–141.
PMCID:
PMC1801305
SummaryPage BrowsePDF–2.2M
17.
Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.
S Vora, S DiMauro, D Spear, D Harker, M J Danon
J Clin Invest. 1987 Nov; 80(5): 1479–1485. doi: 10.1172/JCI113229
PMCID:
PMC442407
SummaryPage BrowsePDF–1.3M
18.
Isozymes of human phosphofructokinase: Identification and subunit structural characterization of a new system
Shobhana Vora, Carol Seaman, Susan Durham, Sergio Piomelli
Proc Natl Acad Sci U S A. 1980 Jan; 77(1): 62–66. doi: 10.1073/pnas.77.1.62
PMCID:
PMC348208
SummaryPage BrowsePDF–1.0M
19.
UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target
Kumar Saurabh, Parag P. Shah, Mark A. Doll, Leah J. Siskind, Levi J. Beverly
BMC Cancer. 2020; 20: 824. Published online 2020 Aug 31. doi: 10.1186/s12885-020-07322-1
PMCID:
PMC7457484
AbstractArticlePDF–3.1M
20.
A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors
M New, H Olzscha, G Liu, O Khan, L Stimson, J McGouran, D Kerr, A Coutts, B Kessler, M Middleton, N B La Thangue
Cell Death Differ. 2013 Oct; 20(10): 1306–1316. Published online 2013 May 24. doi: 10.1038/cdd.2013.47
PMCID:
PMC3770323
AbstractArticlePDF–1.9M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center